BNP Paribas Financial Markets’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,213
Closed -$703 5586
2024
Q3
$703 Sell
1,213
-30,688
-96% -$17.2K ﹤0.01% 3976
2024
Q2
$19.7K Sell
31,901
-14,336
-31% -$12.1K ﹤0.01% 3643
2024
Q1
$119K Buy
46,237
+21,271
+85% +$52K ﹤0.01% 3391
2023
Q4
$50.9K Buy
24,966
+10,248
+70% +$18.7K ﹤0.01% 3560
2023
Q3
$25.3K Sell
14,718
-8,223
-36% -$14.6K ﹤0.01% 3547
2023
Q2
$44.7K Buy
22,941
+22,307
+3,518% +$52.2K ﹤0.01% 3499
2023
Q1
$1.76K Sell
634
-539
-46% -$1.54K ﹤0.01% 3642
2022
Q4
$4.05K Sell
1,173
-4,950
-81% -$14.1K ﹤0.01% 3679
2022
Q3
$15.7K Buy
6,123
+2,683
+78% +$8.54K ﹤0.01% 4130
2022
Q2
$8.32K Sell
3,440
-2,111
-38% -$5.54K ﹤0.01% 3769
2022
Q1
$22.9K Sell
5,551
-11,446
-67% -$60.6K ﹤0.01% 3706
2021
Q4
$219K Buy
16,997
+7,926
+87% +$87.8K ﹤0.01% 3369
2021
Q3
$98K Buy
9,071
+3,370
+59% +$30.7K ﹤0.01% 3284
2021
Q2
$52K Sell
5,701
-5,316
-48% -$49.2K ﹤0.01% 3246
2021
Q1
$104K Buy
11,017
+4,825
+78% +$66.5K ﹤0.01% 3335
2020
Q4
$24.4K Sell
6,192
-1,091
-15% -$3.3K ﹤0.01% 3803
2020
Q3
$19.3K Buy
7,283
+5,822
+398% +$21.6K ﹤0.01% 3842
2020
Q2
$9.7K Sell
1,461
-6,245
-81% -$42.1K ﹤0.01% 3727
2020
Q1
$44.8K Buy
7,706
+4,798
+165% +$40.3K ﹤0.01% 3592
2019
Q4
$26.1K Sell
2,908
-508
-15% -$4.24K ﹤0.01% 3930
2019
Q3
$29.5K Buy
3,416
+1,666
+95% +$16.8K ﹤0.01% 3763
2019
Q2
$19.5K Buy
1,750
+108
+7% +$1.24K ﹤0.01% 3910
2019
Q1
$21.8K Buy
+1,642
New +$21.9K ﹤0.01% 3881

Other funds holding GRTS

BNP Paribas Financial Markets's GRTS Position: Q4 2024 in Review

BNP Paribas Financial Markets sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 1,213 shares — an estimated $703 sold.

BNP Paribas Financial Markets first reported a position in GRTS in Q1 2019 and held it in 23 quarters. The position peaked at $219K in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • BNP Paribas Financial Markets reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,213 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $703.
  • BNP Paribas Financial Markets first reported a position in Gritstone bio, Inc. Common Stock in Q1 2019 and held it in 23 quarters.
  • BNP Paribas Financial Markets's Gritstone bio, Inc. Common Stock position peaked at $219K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2024, filed 14 Feb 2025.